Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,843 | 334 | 40.8% |
| Consulting Fee | $4,281 | 2 | 25.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,500 | 1 | 20.9% |
| Travel and Lodging | $1,147 | 4 | 6.8% |
| Education | $1,000 | 1 | 6.0% |
| Gift | $11.92 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $8,071 | 13 | $0 (2024) |
| ABBVIE INC. | $2,181 | 116 | $0 (2024) |
| Intuitive Surgical, Inc. | $2,175 | 7 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,696 | 70 | $0 (2024) |
| Merck Sharp & Dohme LLC | $461.29 | 27 | $0 (2024) |
| Organon Llc | $401.08 | 33 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $170.31 | 9 | $0 (2022) |
| THD America, Inc. | $164.32 | 3 | $0 (2022) |
| Axonics, Inc. | $138.64 | 7 | $0 (2024) |
| Boston Scientific Corporation | $132.49 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,909 | 96 | Takeda Pharmaceuticals U.S.A., Inc. ($618.96) |
| 2023 | $1,690 | 81 | AbbVie Inc. ($597.54) |
| 2022 | $5,387 | 56 | Medtronic, Inc. ($4,316) |
| 2021 | $7,238 | 87 | Medtronic, Inc. ($3,557) |
| 2020 | $546.06 | 22 | AbbVie Inc. ($140.98) |
| 2019 | $11.55 | 1 | Merck Sharp & Dohme Corporation ($11.55) |
All Payment Transactions
343 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: INFLIXIMAB | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $25.33 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: INFLIXIMAB | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.31 | General |
| Category: Immunology | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $30.22 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/17/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: GI | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: INFLIXIMAB | ||||||
| 10/15/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $0.50 | General |
| Category: INFLIXIMAB | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.04 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Immunology | ||||||
| 09/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: IMMUNOLOGY | ||||||
| 09/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/17/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $11.34 | General |
| Category: INFLIXIMAB | ||||||
| 09/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 239 | 321 | $156,456 | $27,833 |
| 2022 | 7 | 115 | 160 | $40,750 | $12,905 |
| 2021 | 6 | 131 | 187 | $45,735 | $17,025 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $15,477 | $5,914 | 38.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 39 | 41 | $61,312 | $4,915 | 8.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 35 | 49 | $11,673 | $4,792 | 41.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 25 | 85 | $8,560 | $3,317 | 38.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 13 | 13 | $20,210 | $2,719 | 13.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 14 | 14 | $7,245 | $1,881 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,315 | $1,152 | 34.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 15 | $2,527 | $1,002 | 39.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 16 | $4,168 | $975.00 | 23.4% |
| 91122 | Study of rectum sensitivity and function | Facility | 2023 | 11 | 11 | $7,517 | $753.93 | 10.0% |
| 91120 | Test for tone and sensation of rectum and anus | Facility | 2023 | 11 | 11 | $14,453 | $413.27 | 2.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 20 | 27 | $4,726 | $2,787 | 59.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $7,118 | $2,774 | 39.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 47 | $5,619 | $2,565 | 45.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 17 | 17 | $3,327 | $1,534 | 46.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 13 | 13 | $15,835 | $1,254 | 7.9% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 14 | $2,275 | $1,046 | 46.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 13 | 17 | $1,848 | $943.46 | 51.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 37 | 37 | $10,360 | $4,932 | 47.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 66 | $7,590 | $3,789 | 49.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 35 | $5,950 | $3,698 | 62.1% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 12 | 13 | $15,535 | $1,722 | 11.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 18 | 18 | $3,510 | $1,490 | 42.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 16 | 18 | $2,790 | $1,394 | 50.0% |
About Dr. Sarah Stringfield, MD
Dr. Sarah Stringfield, MD is a Surgery healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/21/2012. The National Provider Identifier (NPI) number assigned to this provider is 1972849743.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Stringfield, MD has received a total of $16,782 in payments from pharmaceutical and medical device companies, with $1,909 received in 2024. These payments were reported across 343 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($6,843).
As a Medicare-enrolled provider, Stringfield has provided services to 485 Medicare beneficiaries, totaling 668 services with total Medicare billing of $57,762. Data is available for 3 years (2021–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Other Specialties Colon & Rectal Surgery
- Location Dallas, TX
- Active Since 12/21/2012
- Last Updated 05/04/2022
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1972849743
Products in Payments
- EEA (Device) $4,295
- Da Vinci Surgical System (Device) $2,175
- RINVOQ (Biological) $966.20
- ENTYVIO (Biological) $904.44
- HUMIRA (Biological) $763.66
- GATTEX (Drug) $762.21
- SKYRIZI (Biological) $351.17
- RENFLEXIS (Drug) $349.04
- DIFICID (Drug) $268.02
- BRIDION (Drug) $193.27
- LIGASURE (Device) $141.03
- RESOLUTION CLIP (Device) $132.49
- INTERSTIM (Device) $129.78
- TRULANCE (Drug) $126.89
- OMVOH (Drug) $110.05
- Axonics (Device) $105.25
- Zynrelef (Drug) $102.72
- OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) (Device) $87.13
- NATRELLE SALINE-FILLED BREAST IMPLANTS (Device) $74.99
- ANJESO (Drug) $67.98
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Dallas
Dr. Sachin Kukreja, Md, MD
Surgery — Payments: $612,774
Walton Taylor, Md, MD
Surgery — Payments: $456,616
Dr. Steven Leeds, M.d, M.D
Surgery — Payments: $270,492
Aaron Hoffman, Md, MD
Surgery — Payments: $189,450
Dr. Lam Le, M.d, M.D
Surgery — Payments: $172,557
Walter Peters, M.d., M.b.a, M.D., M.B.A
Surgery — Payments: $76,471